Protalix BioTherapeutics, Inc. (PLX)

ASE – Real vaqt narxi. Valyuta: USD

2.67

+0.24 (10.08%)

Bozor ochiq: Aug 12, 2026, 1:23 PM EDT

2.40

-0.03 (-1.23%)

Oldingi bozordan keyin: Aug 11, 2026, 7:44 PM EDT

Umumiy
Yangiliklar
Grafik
Hisobotlar
Dividendlar
Kutilma
Egalik
Profil

05.08.2026

Protalix BioTherapeutics to Announce Second Quarter 2026 Financial Results and Business Update on August 12, 2026

Company to host conference call and webcast at 8:00 a.m. EDT CARMIEL, Israel, Aug. 5, 2026 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the discovery, development, production, and commercialization of innovative therapeutics for rare diseases with significant unmet needs, today announced that it will release its financial results for the quarter ended June 30, 2026 and provide a business update on August 12, 2026.

Videolar

No Data

There is no data to display

Protalix BioTherapeutics, Inc. (PLX)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Protalix BioTherapeutics, Inc. (PLX)

Protalix BioTherapeutics to Announce Second Quarter 2026 Financial Results and Business Update on August 12, 2026

Videolar

No Data

Protalix BioTherapeutics to Announce Second Quarter 2026 Financial Results and Business Update on August 12, 2026

Videolar

No Data

Search stocks

Protalix BioTherapeutics, Inc. (PLX)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Protalix BioTherapeutics, Inc. (PLX)

Protalix BioTherapeutics to Announce Second Quarter 2026 Financial Results and Business Update on August 12, 2026

Videolar

No Data

Protalix BioTherapeutics to Announce Second Quarter 2026 Financial Results and Business Update on August 12, 2026

Videolar

No Data